Enclomiphene: all 25 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg EnclomipheneCompletedNCT02651688Phase 2Results posted
- Comparison of Two Formulations of AndroxalCompletedNCT01984398Phase 1Results posted
- A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of AndroxalCompletedNCT01959685Phase 1Results posted
- Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary HypogonadismCompletedNCT01739595Phase 3Results posted
- Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary HypogonadismCompletedNCT01534208Phase 3Results posted
- Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary HypogonadismCompletedNCT01532414Phase 3Results posted
- The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)CompletedNCT01386606Phase 2Results posted
- Normalization of Morning Testosterone Levels in Men With Secondary HypogonadismCompletedNCT01270841Phase 2Results posted
- Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusCompletedNCT01191320Phase 2Results posted
- To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical TestosteroneCompletedNCT00706719Phase 2Results posted
- An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral AdministrationCompletedNCT02274181Phase 1
- An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of AndroxalCompletedNCT02169804Phase 1
- Androxal in Male InfertilityWithdrawnNCT02160704Phase 2/3
- Study to Evaluate the Effect of Food Upon the Pharmacokinetics of AndroxalCompletedNCT02146391Phase 1
- A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male SubjectsCompletedNCT02117830Phase 1
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993225Phase 3
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993212Phase 3
- Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy MalesCompletedNCT01991327Phase 1
- Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic FunctionCompletedNCT01923870Phase 1
- Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal FunctionCompletedNCT01923857Phase 1
- An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary HypogonadismCompletedNCT01739582Phase 3
- Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary HypogonadismCompletedNCT01619683Phase 3
- A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203CompletedNCT01386567Phase 2
- Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary HypogonadismCompletedNCT01067365Phase 3
- Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary HypogonadismCompletedNCT00962637Phase 3